Iron deficiency and anemia are commonly diagnosed and can result in significant negative health impacts if not treated. Intravenous iron offers a rapid treatment option that is often superior to oral iron.

Looking for an infusion center?
Check this infusion center website locator.

Background

  • Iron deficiency anemia is the most common blood problem in the world.
  • Iron deficiency can result in anemia, in which not enough red blood cells are available to carry oxygen throughout the body.
  • Symptoms include feeling tired, weak or dizzy and having pale skin, cold hands and feet. Other symptoms include headache, swollen legs, restless leg syndrome, and dry or brittle hair and nails. Occasionally, it can cause chest pain, a fast heartbeat and shortness of breath.
  • Iron deficiency is common in women of reproductive age.

Key points

  • The first line of treatment for low iron levels and anemia is usually oral iron tablets.
  • However, oral iron supplements are often discontinued due to side effects, including gastrointestinal issues. This is especially problematic for individuals suffering from inflammatory bowel disease.
  • In some cases, oral iron supplementation does not increase iron levels or reduce anemia.
  • Medical guidelines for the treatment of iron deficiency anemia are outdated in many countries.

Parsemus' role

  • The Parsemus Foundation provides evidence-based information on better treatment options for common ailments.
  • Intravenous iron infusion offers a rapid recovery from iron deficiency and anemia, often with only one or two treatments.
  • Intravenous iron is preferred over oral iron supplements to replace iron in iron deficient individuals with chronic inflammatory conditions or when oral therapy is poorly tolerated or ineffective.
The Project in Detail

For individuals suffering from iron deficiency anemia, the most common treatment is oral iron supplements. However, intravenous iron allows complete replacement of iron and alleviation of anemia in one (or more) sessions. With the development of safer solutions, IV iron has been used more often for anemic individuals with inflammatory bowel disease, gynecological and obstetric issues, renal failure, and cancer. Yet it is still an underutilized method due to outdated methods and safety concerns. IV iron may be particularly helpful for older individuals, who may not even realize that they have iron deficiency.

Anemia indicates that you don’t have enough healthy red blood cells to carry adequate oxygen to your body’s tissues. Iron deficiency is the most common cause of anemia worldwide, affecting approximately 27% of the world’s population. It is more common in developing countries.

It is important to note that iron deficiency can also occur without anemia, and is at least twice as common as anemia. Iron deficiency without anemia refers to low iron stores that do not meet the body’s iron requirements. It has similar symptoms, diagnosis, and treatment options.

27%

of the world's population is affected
by iron deficiency anemia

Iron deficiency causing anemia may be due to blood loss, menstruation and pregnancy in women and their children, malaria, hookworm, dietary conditions lacking adequate iron, celiac disease, cancer, kidney disease, and conditions causing an inability to absorb iron. About 10% of individuals over 65 years and more than 20% of individuals over 85 years are anemic. Anemia in the elderly is typically mild, but results in  adverse outcomes like longer hospitalization, disability, and increased mortality risk and impacts on quality of life (fatigue, depression, frailty, etc.).

Iron deficiency is extremely common in individuals with chronic inflammation (chronic heart failure, chronic kidney disease, cancers, and bowel inflammatory diseases).

Initially, iron deficiency anemia can be so mild that it goes unnoticed. But as the body becomes more deficient in iron and anemia worsens, the signs and symptoms intensify. Note that iron deficiency without anemia has many of the same symptoms:

  • Extreme fatigue
  • Weakness
  • Pale skin
  • Chest pain, fast heartbeat or shortness of breath
  • Headache, dizziness or lightheadedness
  • Cold hands and feet
  • Restless legs syndrome
  • Inflammation or soreness of your tongue
  • Brittle nails
  • Unusual cravings for non-nutritive substances, such as ice, dirt or starch
  • Poor appetite, especially in infants and children with iron deficiency anemia

Anemia may be identified by the red blood cell count (hematocrit) or hemoglobin level in blood.

To understand if anemia is caused by iron deficiency, serum ferritin (a protein containing iron) is a good test. Ferritin is a simple and inexpensive blood test for iron stores, but doctors may not always prescribe it. You can ask for a ferritin test from your doctor, or order one online through sources such as Ulta Lab Tests or Walk-In-Lab. However, diagnosis of iron deficiency is complicated for individuals with inflammatory diseases such as inflammatory bowel disease because ferritin may appear falsely normal even when iron is actually deficient.

A definitive diagnosis usually considers serum ferritin, percent transferrin saturation (TSAT), and hemoglobin, which correlate best with iron status. The definition of anemia varies according to age, sex, race, and how the blood was collected. An additional complexity is that medical guidelines for testing and interpreting data are not standardized and vary country by country.

Despite the lack of standardization, here is a general guide. Ferritin levels under 50 raise the suspicion of iron deficiency, and levels under 30 mean it is likely. But for individuals with chronic inflammation, ferritin levels under 100 μg/L or TSAT levels below 20% signal iron deficiency.

Iron supplementation is usually the prescribed treatment for anemia. Iron can be taken via oral iron (tablets or liquid) and as an intravascular infusion. Oral iron frequently causes side effects (such as gastrointestinal problems, headache, cramps) leading to discontinuation and treatment failure in a significant portion of people.

Intravenous iron has many benefits over oral iron. A 2015 meta-analysis reported that oral iron supplement caused 2.6 times the odds of  gastrointestinal side-effects compared to placebo or IV iron in participants who were not pregnant and did not have inflammatory bowel disease. Iron provided via IV also has the significant advantage of rapid replenishment of iron throughout the body. Often in as little as one or two transfusions, iron levels are completely recovered. In a randomized, controlled trial, hemoglobin reached a normal level in 80% of anemic women receiving 1-2 intravenous iron transfusions compared to 51% of women using oral iron.

IV iron is especially useful in people with IBD as it bypasses the gut where iron can actually make the symptoms of IBD worse. It is also useful to treat iron deficiency in women with heavy uterine bleeding, pregnancy, bariatric surgery, restless legs syndrome, and high altitude sickness.

Some doctors may be reluctant to use IV iron because an older high-molecular-weight iron called dextran was associated with severe infusion reactions. However, iron formulations used today are much safer.

Intravenous iron is currently underutilized, and  should be considered especially in iron deficient individuals with chronic inflammatory conditions and when oral therapy is poorly tolerated or ineffective.

Elaine Lissner
Elaine Lissner, Founder of the Parsemus Foundation

If you have been diagnosed with iron deficiency with or without anemia, talk to your doctor about treatment options to see if intravenous iron is right for you. To diagnose an iron deficiency, evaluation of serum ferritin level, hemoglobin level, and percent transferrin saturation can be completed. If your doctor is not familiar with the modern use of intravenous iron to treat iron deficiency, the references under Additional Resources below may be useful. To find an iron infusion center, you can try this locator service from the National Infusion Center Association.

Further reading and links

Al-Naseem A, Sallam A, Choudhury S, Thachil J (2021). Iron deficiency without anaemia: a diagnosis that matters. Clinical Medicine 21(2): 107–13. (free full text).

Arastu AH, Elstrott BK, Martens KL, et al. (2022). Analysis of adverse events and intravenous iron infusion formulations in adults with and without prior infusion reactions. JAMA Netw Open. 5(3):e224488. (free full text).

Auerbach M, Deloughery T (2016). Single-dose intravenous iron for iron deficiency: a new paradigm. Hematology, Am Soc Hematol Educ Program 1:57-66. (free full text).

Bhandari S, Pereira DIA, Chappell HF, DrakesmithH (2018). Intravenous irons: From basic science to clinical practice. Pharmaceuticals (Basel). 11(3): 82. (free full text).

Busti F, Campostrini N, Martinelli N, Girelli D (2014). Iron deficiency in the elderly population, revisited in the hepcidin era. Front Pharmacol 5: 83. (free full text).

Cacoub P, Choukroun G, Cohen-Solal A, et al. (2022). Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action. J Intern Med 1–15. (free full text).

Cappellini MD, Santini V, Braxs C, Shander A. (2022). Iron metabolism and iron deficiency anemia in women. Fertil Steril 118(4):607-614. (free full text).

Numan S, Kaluza K. (2020). Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications. Current Medical Research and Opinion, 36:11, 1769-1782. (free full text).

Peyrin-Biroulet L, Williet N, Cacoub P (2015). Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr 102(6):1585-94. (free full text).

Tolkien Z, Stecher L, Mander AP, Pereira DIA, Powell JJ (2015). Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: A systematic review and meta-analysis. PLoS ONE 10(2):1-20. (free full text).

Truong J, Naveed K, Beriault D, et al. (2024). The origin of ferritin reference intervals: a systematic review. Lancet Haematol  Jul;11(7):e530-e539. (abstract).

Van Doren L, Steinheiser L, Boykin K, et al. (2024). Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions. Am J Hematol 99(7):1338-1348. (free full text)

Vanobberghen F, Lweno O, Kuemmerle A, et al. (2021). Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial. Lancet 9:2, e189-e198. (free full text)

Last updated on March 10, 2025

Many urologists have no knowledge of PEMF. I have full body PEMF mat, I have been lying on the mat for 30 minutes per day, in three weeks I have noticeable improvement in my BPH symptoms, reduced my bathroom visits by 50%.

Anonymous,June 2024

The electromagnetic treatment from the PEMF device produced a significant reduction (average 57%) in prostatic volume in three weeks of treatment.

Leoci et al.2014

The efficacy of PEMF (pulsed electromagnetic field therapy) on BPH in dogs, with no side effects, suggests the suitability of this treatment in humans and supports the hypothesis that impairment of blood supply to the lower urinary tract may be a causative factor in the development of BPH.

Leoci et al.2014

It would be great to have a new option such as pulsed electromagnetic field therapy for BPH. The preliminary study in an animal model is promising, but we need more research to determine how effective (and safe) this procedure would be in human men.

Alan ShindelMD

Benign prostatic hyperplasia is an important and under-recognized health issue for men. There is a great need for development of effective and safe alternatives to current treatment options.

Abraham MorgentalerMD, FACS
If you want us to respond remember to include your email address.
This field is for validation purposes and should be left unchanged.